Literature DB >> 26695557

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma.

Lh McCormick Matthews, F Noble, J Tod, E Jaynes, S Harris, J N Primrose, C Ottensmeier, G J Thomas, T J Underwood.   

Abstract

Entities:  

Year:  2015        PMID: 26695557      PMCID: PMC4702008          DOI: 10.1038/bjc.2015.460

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
Correction to: British Journal of Cancer (2015) 113, 107–118; doi:10.1038/bjc.2015.179; published online 25 June 2015 Following the publication of this manuscript, the authors have made arrangements to change the licence from CC-BY-NC-SA to CC-BY 4.0. Therefore the terms under which this paper is published are now altered and further details can be found on the creative commons website http://creativecommons.org/licenses/by/4.0/
  4 in total

Review 1.  Chemokines and their receptors as biomarkers in esophageal cancer.

Authors:  Masakazu Goto; Mingyao Liu
Journal:  Esophagus       Date:  2019-11-26       Impact factor: 4.230

2.  Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus.

Authors:  M Schoemmel; H Loeser; F Gebauer; A Quaas; M Kraemer; S Wagener-Ryczek; A Hillmer; C Bruns; M Thelen; W Schröder; T Zander; A Lechner; R Buettner; H Schlösser
Journal:  Clin Transl Oncol       Date:  2021-02-10       Impact factor: 3.405

3.  A conceptual framework for prognostic research.

Authors:  Peter Kent; Carol Cancelliere; Eleanor Boyle; J David Cassidy; Alice Kongsted
Journal:  BMC Med Res Methodol       Date:  2020-06-29       Impact factor: 4.615

4.  Predictive value of Leukocyte ImmunoTest (LIT™) in cancer patients: a prospective cohort study.

Authors:  Xiaomeng Li; Xiaojun Ma; Yifeng Liu; Enqiang Chang; Jiang Cui; Daqing Ma; Jiaqiang Zhang
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.